Conference Coverage

The oral presentation includes additional results from Blue Earth's Phase 3 SPOTLIGHT study evaluating the impact of clinical factors on the detection rate of 18F-rhPSMA-7.3 PET imaging in men with suspected prostate cancer recurrence based on elevated PSA following prior therapy
News | PET Imaging
Blue Earth Diagnostics Highlights Presentations on Axumin (Fluciclovine F 18) and Investigational 18F-rhPSMA-7.3 in Biochemically Recurrent Prostate Cancer

October 25, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time October 25, 2022
arrow
Healthcare providers able to enhance clinical operations through specialized services for advanced radiation therapy solutions
News | Radiation Oncology
Elekta Increases Value-Added Services and Strengthens its Position as a Life-Time Companion

October 25, 2022 — In order to provide improved efficiency and expertise to its customers, Elekta (EKTA-B.ST) announces ...

Time October 25, 2022
arrow
RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO 2022
News | Radiation Oncology
Latest Innovations in RayStation, RayCare and RayIntelligence to be Presented at ASTRO 2022

October 25, 2022 — RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO ...

Time October 25, 2022
arrow
Randomized trial also finds addition of local treatment could offer patients more time off hormone therapy
News | Prostate Cancer
Radiation-hormone Therapy Combination May Slow Growth of Oligometastatic Prostate Cancer

October 25, 2022 — A new study offers a new option to patients with oligometastatic prostate cancer who want relief from ...

Time October 25, 2022
arrow
Introducing the TotalRT All in One Solution to Quickly Adapt CIVCO RT's Radiotherapy Solutions
News | Radiation Therapy
CIVCO Radiotherapy to Exhibit Most Recent Innovations at ASTRO Annual Meeting

October 24, 2022 — CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric ...

Time October 24, 2022
arrow
Company announces SCINTIX as new product name for its flagship biology-guided radiotherapy technology
News | PET-CT
RefleXion Highlights New Cancer Treatment Research Abstracts for Presentation at ASTRO 2022

October 24, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a ...

Time October 24, 2022
arrow
The MEVION S250-FIT Proton Therapy System (Photo: Business Wire)
News | Proton Therapy
Mevion Introduces New MEVION S250-FIT Proton Therapy System

October 24, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time October 24, 2022
arrow
Randomized trial finds hypofractionated whole-breast radiation with concurrent boost comparable to six weeks of treatment for patients with higher-risk disease
News | Breast Imaging
Three-week Course of Radiation Safe and Effective for Patients with Early-stage Breast Cancer and Elevated Risk of Recurrence

October 24, 2022 — A three-week course of radiation therapy is as safe and effective as four to six weeks of treatment ...

Time October 24, 2022
arrow
Evidence from VA medical centers nationwide supports benefits of prostate cancer screening
News | Prostate Cancer
Lower Prostate Cancer Screening Rates Associated with Subsequent Increase in Advanced Cancers

October 24, 2022 — In the face of conflicting evidence over the risks and benefits of routine prostate cancer screenings ...

Time October 24, 2022
arrow
Randomized phase III trial indicates SBRT is an option for patients ineligible for other local therapies
News | Radiation Oncology
Adding Radiation to Systemic Therapy Extends Overall Survival for Patients with Advanced Liver Cancer

October 24, 2022 — Adding radiation therapy to systemic therapy for patients with advanced liver cancer can extend ...

Time October 24, 2022
arrow
Machine-learning method identifies rapid drops in patients’ activity levels to signal need for additional care
News | Artificial Intelligence
AI Model Using Daily Step Counts Predicts Unplanned Hospitalizations During Cancer Therapy

October 24, 2022 — An artificial intelligence (AI) model developed by researchers can predict the likelihood that a ...

Time October 24, 2022
arrow
Phase II trial suggests radiation could ward off complications of bone lesions and extend overall survival for patients with advanced cancers
News | Radiation Therapy
Radiation Therapy for High-risk, Asymptomatic Bone Metastases May Prevent Pain and Prolong Life

October 23, 2022 — Treating high-risk, asymptomatic bone metastases with radiation may reduce painful complications and ...

Time October 23, 2022
arrow
Randomized, phase III clinical trial finds patients who are educated about technical aspects of care less likely to report high levels of anxiety
News | Radiation Therapy
Medical Physicist Consults with Patients can Help Reduce Anxiety and Increase Satisfaction with Radiation Care

October 23, 2022 — Meeting with a medical physicist who can explain how radiation therapy is planned and delivered ...

Time October 23, 2022
arrow
Ultra-high dose-rate radiation treatment found safe and effective for pain relief in small trial of patients with metastatic cancer
News | Proton Therapy
FLASH Radiation Therapy Shows Promise in First-in-human Trial

October 23, 2022 — FLASH radiation treatment – which delivers therapeutic doses of radiation in a fraction of a second – ...

Time October 23, 2022
arrow
Phase III study provides randomized evidence of equivalent outcomes and side effects with 5 vs. 8 weeks of radiation for high-risk disease
News | Prostate Cancer
Shortened Course of Radiation Therapy Safe and Effective for Men with High-risk Prostate Cancer

October 23, 2022 — A new randomized study confirms that men with high-risk prostate cancer can be treated with five ...

Time October 23, 2022
arrow
Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Proton Therapy
Together with Siemens Healthineers, Varian Showcases Technologies and Services Spanning the Full Cancer Care Continuum at ASTRO 2022

October 21, 2022 — Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end ...

Time October 21, 2022
arrow
Clinical outcome oral presentations on SMART Pancreas and MIRAGE prostate studies Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting
News | Radiation Therapy
MRIdian Clinical Studies and Initial MRIdian A3i Clinical Experience to be Highlighted at ASTRO 2022

October 21, 2022 — ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRIdian MRI-Guided Radiation Therapy ...

Time October 21, 2022
arrow
Study highlights gender disparity in how frequently doctors and clinical trials assess the impact of treatment on sexual health
News | Clinical Case Studies
Sexual Side Effects of Cancer Treatment Often Unaddressed with Female Patients

October 21, 2022 — A new study finds that sexual side effects of cancer treatment are discussed far less frequently with ...

Time October 21, 2022
arrow
18F-SMBT-1 PET studies showed that beta-amyloid+ Alzheimer’s disease (AD) patients, but most importantly, beta-amyloid+ controls (CN) have significantly higher regional 18F-SMBT-1 binding than beta-amyloid- CN, with 18F-SMBT-1 retention highly associated with beta-amyloid burden. These findings suggest that increased 18F-SMBT-1 binding is detectable at the preclinical stages of beta-amyloid accumulation.
News | PET Imaging
Novel PET Imaging Agent Detects Earliest Signs of Alzheimer's Disease

October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B ...

Time October 20, 2022
arrow
FDA 510(k) clearance for AI-enabled Philips MR for Calculating Attenuation (MRCAT) Head and Neck radiotherapy application expands range of MR-only workflows
News | Magnetic Resonance Imaging (MRI)
Philips Advances MR Radiotherapy Imaging and Simulation for Head and Neck Cancers

October 20, 2022 — Royal Philips, a global leader in health technology, announced two new advances in MR-only workflows ...

Time October 20, 2022
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now